Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Original publication

DOI

10.1093/eurheartj/ehv320

Type

Journal article

Journal

Eur Heart J

Publication Date

14/01/2016

Volume

37

Pages

267 - 315

Keywords

Acute cardiac care, Acute coronary syndromes, Angioplasty, Anticoagulation, Apixaban, Aspirin, Atherothrombosis, Beta-blockers, Bivalirudin, Bypass surgery, Cangrelor, Chest pain unit, Clopidogrel, Dabigatran, Diabetes, Early invasive strategy, Enoxaparin, European Society of Cardiology, Fondaparinux, Glycoprotein IIb/IIIa inhibitors, Guidelines, Heparin, High-sensitivity troponin, Myocardial ischaemia, Nitrates, Non-ST-elevation myocardial infarction, Platelet inhibition, Prasugrel, Recommendations, Revascularization, Rhythm monitoring, Rivaroxaban, Statin, Stent, Ticagrelor, Unstable angina, Vorapaxar, Acute Coronary Syndrome, Algorithms, Angina Pectoris, Anticoagulants, Biomarkers, Cardiotonic Agents, Coronary Angiography, Diagnosis, Differential, Electrocardiography, Hemorrhage, Humans, Long-Term Care, Non-ST Elevated Myocardial Infarction, Percutaneous Coronary Intervention, Physical Examination, Platelet Aggregation Inhibitors, Platelet Glycoprotein GPIIb-IIIa Complex, Purinergic P2Y Receptor Antagonists, Risk Assessment